Pediatric IBD: a preliminary vascular signal, without demonstrated cardiovascular risk

Could inflammatory bowel disease (IBD) affect blood vessels as early as childhood? A systematic review with meta-analysis identifies a signal consistent with early impairment of their function. But this finding is based on few participants and does not demonstrate an increase in cardiovascular disease in adulthood.

Illustration of the vascular and lipid markers studied in pediatric IBD.
NutritionEditorial illustration, not study data.

Comparing vascular markers and lipids

The researchers compared people with pediatric or childhood-onset IBD with controls. Their literature search, conducted across several scientific databases through April 24, 2025, covered vascular markers, blood pressure and blood lipid levels.

The sample size and number of studies varied depending on the parameter analyzed. The available abstract does not specify how long participants were followed. It therefore cannot describe how these markers change over the years.

A lower vascular reactivity index

The main signal concerns the reactive hyperemia index, or RHI. Across three studies involving 109 participants, this index was on average 0.25 lower in people with IBD, with a 95% confidence interval ranging from −0.48 to −0.02.

According to the authors, this finding suggests possible early endothelial dysfunction, meaning impaired function of the inner lining of blood vessels. However, it is an intermediate marker, not a measure of future heart attacks or other cardiovascular events. The authors themselves describe the evidence as preliminary.

The other findings do not confirm a uniformly impaired profile

The six studies examining carotid intima-media thickness showed no statistically significant difference. The main analyses also detected no significant difference in diastolic blood pressure or blood lipids. This is not enough to establish equivalence between the groups.

For systolic blood pressure, the main analysis of ten studies found a mean difference of 0.84 mmHg, which was not statistically significant. After one influential study was excluded, a small difference of 1.89 mmHg emerged. This sensitivity to study selection limits the robustness of the conclusion.

A signal to follow up, not an individual prediction

Above all, this review supports further research. Prospective cohorts are needed to determine whether the observed differences persist and truly predict more cardiovascular disease in adulthood. On its own, it does not provide a basis for a new screening or treatment protocol.

Limitations to keep in mind

Only the PubMed abstract was consulted, not the full text. The RHI finding is based on three studies and 109 participants. Details of heterogeneity, treatments and confounding factors are not available in the dossier. Funding and conflicts of interest were not checked.

What we can take away

A lower vascular index emerges from a small set of studies on pediatric IBD. This signal warrants confirmation and should not be equated with demonstrated future cardiovascular risk.

Sources and provenance

Partager cet article

X f in

An error or a source to report? Contact the editorial team.